References
- Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 2004; 427: 167–171
- Lobry C, Lopez T, Israël A, Weil R. Negative feedback loop in T cell activation through I{kappa}B kinase-induced. Proc Natl Acad Sci USA 2007; 104: 908–913
- Martin-Subero J I, Klapper W, Sotnikova A, Callet-Bauchu E, Harder L, Bastard C, , Deutsche Krebshilfe Network Project Molecular Mechanisms in Malignant Lymphomas, et al. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res 2006; 66: 10332–10338
- Re D, Benenson E, Wolf J, Diehl V, Staratschek-Jox A. Lack of BCL10 mutations in Hodgkin's disease-derived cell lines. Br J Haematol 2000; 109: 420–422
- Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne R D, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851–862
- Gross O, Gewies A, Finger K, Schafer M, Sparwasser T, Peschel C, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006; 442: 651–656
- Dong W, Liu Y, Peng J, Chen L, Zou T, Xiao H, et al. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappa B from toll-like receptor 4. J Biol Chem 2004; 279: 37436–37444
- Schwering I, Brauninger A, Klein U, Jungnickel B, Tinguely M, Diehl V, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003; 101: 1505–1512
- Re D, Kuppers R, Diehl V. Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol 2005; 23: 6379–6386